Its announcement will come around the heels of an analogous licensing arrangement presented in February to Adastra Labs, which experienced right until now focused on crafting cannabis extracts. Adastra's license also permits it to make and provide psilocybin and psilocin – hallucinogens much more typically called magic mushrooms that generate con